Wellington Management Group LLP boosted its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 0.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,734,743 shares of the company's stock after buying an additional 76,490 shares during the period. Wellington Management Group LLP owned 12.63% of Acadia Healthcare worth $465,283,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Lindbrook Capital LLC increased its holdings in shares of Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock valued at $29,000 after acquiring an additional 671 shares during the period. Blue Trust Inc. increased its stake in Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after buying an additional 345 shares during the period. Nisa Investment Advisors LLC raised its position in Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after buying an additional 301 shares during the last quarter. Signaturefd LLC boosted its holdings in shares of Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock valued at $48,000 after acquiring an additional 1,004 shares in the last quarter. Finally, Fifth Third Bancorp increased its stake in shares of Acadia Healthcare by 56.0% during the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after acquiring an additional 454 shares during the period.
Acadia Healthcare Price Performance
ACHC traded down $1.01 during midday trading on Friday, reaching $27.37. 1,613,368 shares of the company's stock were exchanged, compared to its average volume of 1,422,644. The business's 50-day moving average price is $35.62 and its 200 day moving average price is $43.35. The stock has a market capitalization of $2.54 billion, a PE ratio of 8.97, a P/E/G ratio of 1.46 and a beta of 1.38. Acadia Healthcare Company, Inc. has a 1-year low of $26.72 and a 1-year high of $82.41. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.
Analyst Ratings Changes
A number of equities research analysts have weighed in on the company. Royal Bank of Canada lowered their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $52.00 price objective on shares of Acadia Healthcare in a report on Tuesday, December 10th. StockNews.com cut Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Monday, January 6th. TD Cowen decreased their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating on the stock in a research report on Tuesday, January 7th. Finally, Mizuho reduced their price objective on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a research note on Tuesday, March 25th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $52.19.
Check Out Our Latest Research Report on Acadia Healthcare
Acadia Healthcare Company Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Stories

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.